Wei Gu
- Geriatrics and Gerontology top 0.01%
- Sirtuins and Resveratrol in Medicine 32
- Cancer Research top 0.05%
- Cancer, Hypoxia, and Metabolism 29
- Aging top 0.2%
- Oncology top 0.05%
- Cancer-related Molecular Pathways 72
- Molecular Biology top 0.05%
- Ubiquitin and proteasome pathways 60
- Epigenetics and DNA Methylation 42
- RNA modifications and cancer 32
-
- Ferroptosis and cancer prognosis 30
-
- Autophagy in Disease and Therapy 24
- Co-authors
- Christopher BrooksDelin ChenNing KonMuyang LiLe JiangRichard BaerShang-Jui WangTongyuan Li
- Partner nations
- United StatesChinaCanada
In The Last Decade
Wei Gu
184 papers receiving 34.8k citations
Hit Papers
Peers
Comparison fields: 5 of 152
- Geriatrics and Gerontology 5.7k
- Cancer Research 8.6k
- Aging 781
- Oncology 10.1k
- Molecular Biology 24.1k
Countries citing papers authored by Wei Gu
This map shows the geographic impact of Wei Gu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei Gu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei Gu more than expected).
Fields of papers citing papers by Wei Gu
This network shows the impact of papers produced by Wei Gu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei Gu. The network helps show where Wei Gu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Wei Gu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2025 | 4 | |
| 3 | 2024 | 2 | |
| 4 | 2024 | 15 | |
| 5 | 2024 | 18 | |
| 6 | 2023 | 80 | |
| 7 | 2023 | 36 | |
| 8 | 2023 | 34 | |
| 9 | 2022 | 2 | |
| 10 | 2022 | 72 | |
| 11 | 2020 | 18 | |
| 12 | 2020 | 70 | |
| 13 | The Deubiquitylase OTUB1 Mediates Ferroptosis via Stabilization of SLC7A11breakdown → | 2019 | 379 |
| 14 | 2017 | 162 | |
| 15 | 2010 | 127 | |
| 16 | 2009 | 62 | |
| 17 | 2008 | 86 | |
| 18 | 2005 | 283 | |
| 19 | Deacetylation of p53 modulates its effect on cell growth and apoptosisbreakdown → | 2000 | 681 |
| 20 | Role of PML in p53-dependent apoptosis. | 2000 | 1 |
About Wei Gu
Wei Gu is a scholar working on Geriatrics and Gerontology, Cancer Research and Oncology, having authored 188 papers that have together received 35.2k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (72 papers), Ubiquitin and proteasome pathways (60 papers), Epigenetics and DNA Methylation (42 papers), RNA modifications and cancer (32 papers), Sirtuins and Resveratrol in Medicine (32 papers), Ferroptosis and cancer prognosis (30 papers), Cancer, Hypoxia, and Metabolism (29 papers) and Autophagy in Disease and Therapy (24 papers). The work is most often cited by research in Geriatrics and Gerontology (5.7k citations), Cancer Research (8.6k citations) and Aging (781 citations). Wei Gu has collaborated with scholars based in United States, China and Canada. Frequent co-authors include Christopher Brooks, Delin Chen, Ning Kon, Muyang Li, Le Jiang, Richard Baer, Shang-Jui Wang, Tongyuan Li, Yingming Zhao and Anatoly Nikolaev. Their work appears in journals such as Cell, Journal of Biological Chemistry, Molecular Cell, Cell Death and Differentiation and Nature.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.